Requests that the FDA determine whether the NDA holder (Long Grove Pharmaceuticals, LLC) for Vasopressin Sodium Chloride 0.9%, 50 units/50 mL (1 unit/mL) (NDA 217766) has withdrawn the product for reasons of safety or efficacy.
🏛 Food and Drug Administration (FDA)FDA-2026-P-0525
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
- Notice· Jul 6, 2026No comment period